2024 Publications
December
- The Dual Endothelin A and Angiotensin II Type 1 Receptor Antagonist Sparsentan (Filspari) Exhibits a Safe Nonclinical Male Fertility Toxicity Profile
Patricia Bedard, Francesca Pretty, Sima Patel, Celia Jenkinson, Tacey White, Donald Kohan
Regulatory Toxicology and Pharmacology - Sex Differences in Response to the Endothelin Receptor Antagonist Atrasentan in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A Post hoc analysis of the SONAR Trial
J David Smeijer, Sieta T de Vries, Donald Kohan, Fan Fan Hou, Hiddo Heerspink
Diabetologia - Endothelin Receptor Antagonists in Chronic Kidney Disease
J David Smeijer, Donald Kohan, Neeraj Dhaun, Irene Noronha, Adrian Liew, Hiddo Heerspink
Nature Reviews Nephrology
November
- Soluble (Pro)Renin Receptor as a Novel Regulator of Renal Medullary Na+ Reabsorption
Tianxin Yang, Zhong-Xiuzi Gao, Zi-Hui Mao, Peng Wu
American Journal of Physiology-Renal Physiology - Baseline Diastolic BP and BP-Lowering Effects on Cardiovascular Outcomes and All-Cause Mortality: A Meta Analysis
Amara Sarwal, Robert Boucher, Sydney Hartsell, Guo Wei, Jincheng Shen, Glenn Chertow, Paul Whelton, Alfred Cheung, John William McEvoy, Tom Greene, Srinivasan Beddhu
Journal of the American Society of Nephrology - Gitelman Syndrome Patient Managed with Amiloride during Pregnancy and Lactation
Abdelrahman Ibrahim, Aylin Rodan, Christof Westenfelder, Laith Al-Rabadi
BMC Nephrology - Sparsentan and Kidney Protection: Improved Medullary Oxygenation? - Authors' Reply
Donald Kohan, Jula Inrig, Brad H Rovin, Radko Komers
The Lancet - Reverse Epidemiology of obesity paradox: Fact or fiction?
Kishore Bellamkonda
Physiological Reports - Low-frequency Variants in Genes Involved in Glutamin Acid Metabolism and y-Glutamyl Cycle and Risk of Coronary Artery Disease in Type 2 Diabetes
Fernando M A Giuffrida, Sharan K Rai, Yaling Tang, Christine Mendonca, Scott G Frodsham, Hetal S Shah, Marcus Pezzolesi, Qi Sun, Alessandro Doria
Cardivascular Diabetology - Ocular Coherence Tomography Unveils Alport Syndrome: A Critical Took in Detecting Collagen IV Nephropathies
Abdelrahman Ibrahim, Zena Altawallbeh, Monica Patricia Revelo, Martin Gregory, Laith Al-Rabadi
Case Reports in Nephrology - The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease
Amara Sarwal, Robert Boucher, Azeem Mohammed, Evan Oro, Farahnaz Akramimoghaddam, Niharika Katkam, Augustine Takyi, George Bissada, Akhil Chakravartula, Terrence Bjordahl, Guo Wei, Srinivasan Beddhu
Contemporary Clinical Trials